# Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch

> **NCT01067781** · PHASE2 · COMPLETED · sponsor: **Intercell USA, Inc.** · enrollment: 600 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **BIOLOGICAL:** Heat-Labile Enterotoxin of E. coli (LT)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01067781
- **Lead sponsor:** Intercell USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-09
- **Final completion:** 2012-03
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2020-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01067781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01067781, "Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01067781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*